Skip to main content
. Author manuscript; available in PMC: 2020 Feb 17.
Published in final edited form as: J Pediatr Adolesc Gynecol. 2013 May 29;26(4):234–238. doi: 10.1016/j.jpag.2013.03.007

Table 4.

Factors associated with recommendation for metformin and hormonal contraceptives

Odds Ratio 95% CI
Metformin
 Specialty
  PGyn vs. PEndo 0.10 0.04, 0.30
  AMed vs. PEndo 0.04 0.01, 0.12
 Obesity (>95th percentile BMI) 4.20 1.79, 9.86
Hormonal contraceptives
 Specialty
  PGyn vs. PEndo 5.80 1.20, 27.73
  AMed vs. PEndo 3.87 1.01, 14.83

Note: CI= confidence interval; AMed, Adolescent Medicine; BMI, body mass index; PEndo, Pediatric Endocrinology; PGyn, Pediatric and Adolescent Gynecology.